India's Cohance Lifesciences set for worst day in 3 yrs on lower Q1 profit

** Shares of Cohance Lifesciences COHA.NS decline 6.8% to 918.7 rupees; on track for biggest intraday pct drop since August 2022

** Pharma co posts a 35% drop in first-quarter consol net profit; rev jumps ~13% but expenses are also up 22%

** About 327,000 shares traded, 1.7x the 30-day avg

** Year-to-date, stock down ~19%

** Despite Q1 results, stock rated "strong buy" on avg, median PT is 1,235 rupees